Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetAlpha-synuclein
LigandBDBM207900
Substrate/Competitorn/a
Meas. Tech.In Vitro Inhibition Assay
EC50 147±n/a nM
Citation Griffioen, GVan Dooren, TRojas De La Parra, VAllasia, SMarchand, AKilonda, AChaltin, P Compounds for the treatment of neurodegenerative diseases US Patent US9266832 Publication Date 2/23/2016
More Info.:Get all data from this article,  Assay Method
 
Alpha-synuclein
Name:Alpha-synuclein
Synonyms:NACP | PARK1 | SNCA | SYUA_HUMAN
Type:Protein
Mol. Mass.:14451.42
Organism:Homo sapiens (Human)
Description:P37840
Residue:140
Sequence:
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTK
EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDP
DNEAYEMPSEEGYQDYEPEA
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM207900
n/a
NameBDBM207900
Synonyms:US9266832, Cpd057
TypeSmall organic molecule
Emp. Form.C25H23ClN2O2
Mol. Mass.418.915
SMILESCOc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: